TIFFANY KOEHN: Open Payments
NPI 1629213665 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 19 payments from 11 companies in 2025. Trend: 2023 $19 · 2024 $23 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $19 |
| Cranial Technologies, Inc | 1 | $19 |
| Corium, LLC | 1 | $18 |
Products named: ARISTADA, CAPLYTA, REXULTI, Jornay PM, AUSTEDO XR, VRAYLAR, Xelstrym, Doc Band.
Industry payments across KS — which companies pay providers there.
